Federal Data Hub › HRSA 340B · JSON
MAINE HEMOPHILIA AND THROMBOSIS CENTER · 340B ID HM04101
ParticipatingHemophilia Treatment Center
MAINE MEDICAL CENTER is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in PORTLAND, ME. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 19 contract-pharmacy arrangement(s) (15 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| EVERSANA LIFE SCIENCE SERVICES, LLC | CHESTERFIELD, MO | 2014-10-01 | 2017-01-30 | 91134 |
| MAINEHEALTH | PORTLAND, ME | 2022-04-01 | — | 95460 |
| NEW ENGLAND LIFE CARE | SCARBOROUGH, ME | 2014-01-01 | — | 10484 |
| OPTUM INFUSION SERVICES 101, INC. | FARMINGDALE, NY | 2023-07-01 | — | 21203 |
| OPTUM INFUSION SERVICES 201, INC. | OVIEDO, FL | 2022-07-01 | — | 39217 |
| OPTUM INFUSION SERVICES 305, LLC | LENEXA, KS | 2022-07-01 | — | 62882 |
| OPTUM INFUSION SERVICES 305, LLC | PLYMOUTH MEETING, PA | 2022-07-01 | — | 25467 |
| OPTUM INFUSION SERVICES 500, INC. | IRWINDALE, CA | 2022-07-01 | 2023-04-05 | 120225 |
| OPTUM INFUSION SERVICES 500, INC. | WALLINGFORD, CT | 2023-07-01 | — | 122415 |
| OPTUM INFUSION SERVICES 550, LLC | WOBURN, MA | 2023-07-01 | — | 13688 |
| OPTUM INFUSION SERVICES 550, LLC | CINCINNATI, OH | 2022-07-01 | — | 50817 |
| OPTUM INFUSION SERVICES 551, LLC | WINDSOR, CT | 2022-07-01 | 2023-04-05 | 91178 |
| OPTUM PHARMACY 701, LLC | FLINT, MI | 2023-07-01 | — | 132743 |
| OPTUM PHARMACY 702, LLC | JEFFERSONVILLE, IN | 2023-07-01 | — | 90281 |
| OPTUM PHARMACY 801, INC. | PHOENIX, AZ | 2023-07-01 | — | 119478 |
| OPTUMRX | OVERLAND PARK, KS | 2023-07-01 | — | 62851 |
| POSITUDES INC | WESTBURY, NY | 2022-07-01 | — | 8621 |
| RED CHIP OF NEVADA | IRVINE, CA | 2015-04-01 | — | 95592 |
| Red Chip of Nevada | Irvine, CA | 2015-10-06 | 2024-02-05 | 99860 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.